Literature DB >> 28584062

Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.

Mizanur M Rahaman1, Anh T Nguyen1, Megan P Miller1, Scott A Hahn1, Courtney Sparacino-Watkins1, Soma Jobbagy1, Nolan T Carew1, Nadiezhda Cantu-Medellin1, Katherine C Wood1, Catherine J Baty1, Francisco J Schopfer1, Eric E Kelley1, Mark T Gladwin1, Emil Martin1, Adam C Straub2.   

Abstract

RATIONALE: Soluble guanylate cyclase (sGC) heme iron, in its oxidized state (Fe3+), is desensitized to NO and limits cGMP production needed for downstream activation of protein kinase G-dependent signaling and blood vessel dilation.
OBJECTIVE: Although reactive oxygen species are known to oxidize the sGC heme iron, the basic mechanism(s) governing sGC heme iron recycling to its NO-sensitive, reduced state remain poorly understood. METHODS AND
RESULTS: Oxidant challenge studies show that vascular smooth muscle cells have an intrinsic ability to reduce oxidized sGC heme iron and form protein-protein complexes between cytochrome b5 reductase 3, also known as methemoglobin reductase, and oxidized sGC. Genetic knockdown and pharmacological inhibition in vascular smooth muscle cells reveal that cytochrome b5 reductase 3 expression and activity is critical for NO-stimulated cGMP production and vasodilation. Mechanistically, we show that cytochrome b5 reductase 3 directly reduces oxidized sGC required for NO sensitization as assessed by biochemical, cellular, and ex vivo assays.
CONCLUSIONS: Together, these findings identify new insights into NO-sGC-cGMP signaling and reveal cytochrome b5 reductase 3 as the first identified physiological sGC heme iron reductase in vascular smooth muscle cells, serving as a critical regulator of cGMP production and protein kinase G-dependent signaling.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  guanosine; heme; iron; nitric oxide; reactive oxygen species

Mesh:

Substances:

Year:  2017        PMID: 28584062      PMCID: PMC5527687          DOI: 10.1161/CIRCRESAHA.117.310705

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  57 in total

1.  Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.

Authors:  Tian Xia; Christiana Dimitropoulou; Jingmin Zeng; Galina N Antonova; Connie Snead; Richard C Venema; David Fulton; Shuibing Qian; Cam Patterson; Andreas Papapetropoulos; John D Catravas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-09-14       Impact factor: 4.733

2.  Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.

Authors:  Sabine Meurer; Sylke Pioch; Tatjana Pabst; Nils Opitz; Peter M Schmidt; Tobias Beckhaus; Kristina Wagner; Simone Matt; Kristina Gegenbauer; Sandra Geschka; Michael Karas; Johannes-Peter Stasch; Harald H H W Schmidt; Werner Müller-Esterl
Journal:  Circ Res       Date:  2009-05-28       Impact factor: 17.367

3.  Localization of the heme binding region in soluble guanylate cyclase.

Authors:  Y Zhao; M A Marletta
Journal:  Biochemistry       Date:  1997-12-16       Impact factor: 3.162

4.  NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy.

Authors:  Philipp Kalk; Michael Godes; Katharina Relle; Christiane Rothkegel; Andreas Hucke; Johannes-Peter Stasch; Berthold Hocher
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

5.  Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.

Authors:  James C Sacco; Lauren A Trepanier
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

6.  Characterization of functional heme domains from soluble guanylate cyclase.

Authors:  David S Karow; Duohai Pan; Joseph H Davis; Sönke Behrends; Richard A Mathies; Michael A Marletta
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

7.  Genomic organization of alpha1 and beta1 subunits of the mammalian soluble guanylyl cyclase genes.

Authors:  I G Sharina; J S Krumenacker; E Martin; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

8.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.

Authors:  Arnab Ghosh; Cynthia J Koziol-White; Kewal Asosingh; Georgina Cheng; Lisa Ruple; Dieter Groneberg; Andreas Friebe; Suzy A A Comhair; Johannes-Peter Stasch; Reynold A Panettieri; Mark A Aronica; Serpil C Erzurum; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

10.  Evidence that cytochrome b5 and cytochrome b5 reductase can act as sole electron donors to the hepatic cytochrome P450 system.

Authors:  Colin J Henderson; Lesley A McLaughlin; C Roland Wolf
Journal:  Mol Pharmacol       Date:  2013-03-25       Impact factor: 4.436

View more
  35 in total

Review 1.  NO as a multimodal transmitter in the brain: discovery and current status.

Authors:  John Garthwaite
Journal:  Br J Pharmacol       Date:  2018-12-05       Impact factor: 8.739

2.  Targeting Pulmonary Endothelial Hemoglobin α Improves Nitric Oxide Signaling and Reverses Pulmonary Artery Endothelial Dysfunction.

Authors:  Roger A Alvarez; Megan P Miller; Scott A Hahn; Joseph C Galley; Eileen Bauer; Timothy Bachman; Jian Hu; John Sembrat; Dmitry Goncharov; Ana L Mora; Mauricio Rojas; Elena Goncharova; Adam C Straub
Journal:  Am J Respir Cell Mol Biol       Date:  2017-12       Impact factor: 6.914

3.  Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.

Authors:  Brittany G Durgin; Scott A Hahn; Heidi M Schmidt; Megan P Miller; Neha Hafeez; Ilka Mathar; Daniel Freitag; Peter Sandner; Adam C Straub
Journal:  JCI Insight       Date:  2019-10-03

4.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

Review 5.  Redox Control of Vascular Function.

Authors:  Joseph C Galley; Adam C Straub
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12       Impact factor: 8.311

Review 6.  Redox control of vascular smooth muscle cell function and plasticity.

Authors:  Brittany G Durgin; Adam C Straub
Journal:  Lab Invest       Date:  2018-02-20       Impact factor: 5.662

Review 7.  Nitric oxide signalling in cardiovascular health and disease.

Authors:  Charlotte Farah; Lauriane Y M Michel; Jean-Luc Balligand
Journal:  Nat Rev Cardiol       Date:  2018-02-01       Impact factor: 32.419

Review 8.  Redox regulation of soluble guanylyl cyclase.

Authors:  Rohan C Shah; Subramaniam Sanker; Katherine C Wood; Brittany G Durgin; Adam C Straub
Journal:  Nitric Oxide       Date:  2018-03-22       Impact factor: 4.427

Review 9.  Role of Thioredoxin in Age-Related Hypertension.

Authors:  Kumuda C Das; Venkatesh Kundumani-Sridharan; Jaganathan Subramani
Journal:  Curr Hypertens Rep       Date:  2018-02-14       Impact factor: 5.369

10.  GAPDH delivers heme to soluble guanylyl cyclase.

Authors:  Yue Dai; Elizabeth A Sweeny; Simon Schlanger; Arnab Ghosh; Dennis J Stuehr
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.